Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

TZOO, ULTA, UBSI, PWRM, HIRU Stock Market News Report from Stock-PR.com

Stock-PR Reporting

stockpr_logo-site

 

FREE Daily Stock Alerts From Stock-PR.com

chartstockalert

________________________________________

 

Power3 Medical Products, Inc. (OTC:PWRM) a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases, announced recently that it has signed a definitive agreement to acquire all of the stock of Rozetta-Cell Life Sciences, Inc. Power3 plans to effectuate the acquisition of Rozetta-Cell by merging Rozetta-Cell with and into Power3, with Power3 remaining as the surviving company in the merger.

 

http://pennyomega.com/img/pwrm_highlight2.jpg

Rozetta-Cell is a medical biotechnology company that focuses on the delivery and imaging of stem cells during therapy. The company has a robust intellectual property portfolio and has created numerous products for adult stem cell therapy that are ready for market globally. Rozetta-Cell also has several collaborations in process through which it is partnering with industry-leading adult stem cell research companies and adult stem cell vendors.

"We are very excited to be acquiring Rozetta-Cell Life Sciences," stated Ira L. Goldknopf, President and Chief Scientific Officer of Power3 Medical Products, Inc. "Rozetta-Cell brings us a tremendous amount of complementary adult stem cell therapy technology, know-how and experience. With the addition of Rozetta-Cell, Power3 will significantly strengthen its IP portfolio in a major growth market by merging regenerative medicine with the technologies that we are using to identify disease-specific protein biomarkers and develop them into screening and diagnostic tests to address unmet medical needs."

Completion of the merger is subject to customary closing conditions, including receipt by the parties of all necessary board and shareholder approvals and third party consents. There can be no assurance that these conditions will be met or that the merger will be completed.

PWRM also recently announced that it delivered four poster presentations at the 2010 International Conference on Alzheimer's Diseasein Honolulu, Hawaii. These presentations discussed NuroPro, Power3's diagnostic test, and focused on Power3's Alzheimer's disease blood serum biomarkers, test and clinical validation trials.

Power3 has filed several patent applications for its NuroPro® technology that are currently pending. Power3 also has a world-wide exclusive license from the Baylor College of Medicine in Houston, Texas. To date, Power3 has given 9 presentations on NuroPro at international scientific meetings in the United States, Europe and China, and has published 6 articles in peer-reviewed scientific journals on the subject. Power3 intends to publish these latest findings as well.

Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig's disease). Power3 applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro®, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer's, Parkinson's and ALS diseases, for which it is currently engaged in Phase II clinical trials. These tests are designed to analyze an individual's proteins to detect the presence of disease, a patient's disease progression, a patient's response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.

**************

 

Hiru Corporation (OTCPK:HIRU) is considering a merger with a Canada-based health products company. This company operates a full-service natural health clinic and distributes its signature brand of health products.

 

http://pennyomega.com/img/hiru_highlight2.jpg

 

The company's various products promote brain health, pain management and hormone balance, and help combat high blood pressure and high cholesterol. These products come highly regarded by the Chinese market, and have already received positive online testimonials from consumers who say using the products improved their health.

Hiru Corporation's Shuangshi AHP Co.'s sales department recently held a large-scale product promotion fair. Shuangshi AHP Co.'s sales department held a large-scale product promotion fair to present its customers the opportunity to review the full roster of Shuangshi AHP Co.'s animal health products and offer the sales force the opportunity to connect and create closer ties with their customers. The fair attracted many people, with many customers placing orders right on the spot. The total order amount generated about 300,000 Yuan (approximately $45,000 USD) by the end of the fair.

Hiru Corporation and its main subsidiary Jiangxi Shuangshi Animal Health Products Co. (Shuangshi AHP Co.) focus on the development, manufacturing and marketing of a broad range of veterinary products for the Chinese Agricultural market. The company has established a strong position in the Chinese animal husbandry market and plans to expand and deliver more new products and solutions to this market in the future.

**************

Travelzoo Inc. (Nasdaq:TZOO) recently announced the winners for the 2010 Travelzoo Awards at the fourth annual gala ceremony in Phoenix last night. Also known as "The Tzoos," the Travelzoo Awards celebrate the companies behind the best travel and entertainment deals of the year. Travelzoo's global team of deal experts evaluated over 80,000 offers to uncover the 17 Travelzoo Award winners.

Travelzoo Inc. is a global Internet media company. The Company informs over 20 million subscribers worldwide, as well as millions of Website users, about the best travel and entertainment deals available from thousands of companies.


**************

Ulta Salon, Cosmetics & Fragrance, Inc. (Nasdaq:ULTA) announced recently that the Company will conduct a conference call to discuss third quarter fiscal 2010 results on Thursday, December 2, 2010 at 5:00 p.m. Eastern Time/ 4:00 p.m. Central Time. A press release detailing the Company’s third quarter fiscal 2010 results will be issued after the market closes and prior to the call.

Ulta Salon, Cosmetics & Fragrance, Inc. is a beauty retailer that provides one-stop shopping for prestige, mass and salon products and salon services in the United States.


**************

United Bankshares, Inc. (Nasdaq:UBSI) announced recently that its Board of Directors declared a fourth quarter dividend of $0.30 per share for shareholders of record as of December 10, 2010. Dividends per share of $1.20 for the year 2010 represents a 3% increase over the $1.17 per share paid for the year of 2009. The dividend payout of approximately $13.1 million on 43.6 million shares is payable January 3, 2011.


United Bankshares, Inc. is a bank holding company. The Bank has two banking subsidiaries doing business under the name of United Bank, operating United Bank and United Bank.

 

 

**************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer).Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services from Power 3 Medical Products Inc. (OTC:PWRM). Crown Equity Holdings Inc. (OTCPK:CRWE) has received five thousand dollars and anticipates receiving another forty five thousand dollars in cash from a third party for (thirty) days of advertising for Hiru Corporation (OTCPK:HIRU)

Sign Up For Free Stock Alerts At http://stock-pr.com/signup

http://stock-pr.com/img/stock-pr_buscard.jpg

________________________________________

Be Sure To Visit stock-pr.ning.com

**********************************************************************

The views expressed in any article, reports, writings are not necessarily the views of Crown Equity Holdings Inc. its officers, directors, staff, contractors or employees. They do not represent the views or opinions of this site. Views expressed in articles are those of the author alone.